Status:
COMPLETED
Management of Acute Pulmonary Hypertensive Crisis in Children With Known Pulmonary Arterial Hypertension
Lead Sponsor:
Stanford University
Conditions:
Pulmonary Arterial Hypertension
Eligibility:
All Genders
1-18 years
Phase:
PHASE4
Brief Summary
Pulmonary arterial hypertension (PAH) is a disease where the blood pressure in the pulmonary arteries (PAP) is high. PAH increases the risk of adverse events, including death, during and or after proc...
Detailed Description
Pulmonary arterial hypertension (PAH) is a disease where the blood pressure in the pulmonary arteries (PAP) is high. PAH increases the risk of adverse events, including death, during and or after proc...
Eligibility Criteria
Inclusion
- Patients presenting for cardiac catheterization procedure with a diagnosis of PAH either by previous cardiac catheterization or echocardiography
Exclusion
- Children presenting for cardiac catheterization who do not have PAH;
- Children with PAH but with intracardiac shunts
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT05439460
Start Date
January 1 2012
End Date
June 1 2014
Last Update
August 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiac Catheterization Lab,Stanford University Medical Center
Stanford, California, United States, 94043